Benchmark analyst Josh Sullivan maintains Ultralife (NASDAQ:ULBI) with a Buy and raises the price target from $12 to $13.
- Headlines
- Benchmark Maintains Buy on Ultralife, Raises Price Target to $13
Benchmark Maintains Buy on Ultralife, Raises Price Target to $13
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
17:45
Volkswagen labor and management did not reach an agreement in the fourth round of collective bargaining, and the possibility of closing the factory cannot be ruled out
VWAGY+1.11%
17:41
Testimony from Israeli Prime Minister Netanyahu: I waited eight years for this moment. I am speaking about the truth as I remember it, which is important for justice.
17:41
Banks received notification: A video conference will be held in mid-month for the comprehensive implementation of the individual Retirement system.